#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in intestine Chronic graft versus host disease in skin Brain abscess Atopic keratoconjunctivitis Mantle cell lymphoma B-cell small lymphocytic lymphoma refractory Blastic plasmacytoid dendritic cell neoplasia Basal cell naevus syndrome Juvenile chronic myelomonocytic leukaemia Central nervous system lymphoma Hereditary optic atrophy Adenocarcinoma pancreas Stargardt's disease Mantle cell lymphoma stage II Staphylococcal infection More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic Thrombotic thrombocytopenic purpura – Life with Disease SAPHO syndrome – Life with Disease Congenital nephrogenic diabetes insipidus Krabbe’s disease – Diagnostics Splenic marginal zone lymphoma – Treatment Angiosarcoma non-metastatic – Diagnostics Marginal zone lymphoma – Basic Information Congenital generalised lipodystrophy – Diagnostics Urea cycle disorder – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Citrate Haemophilus Influenzae Atropine Sulfate Gedatolisib Phenylalanine Ampicillin Sodium PROMESTRIENE Gen1055 AZD4512 Histidine Mecasermin Rinfabate Pegfilgrastim Bay 3018250 Trehalose Dihydrate (Ph.eur.) SRSD107 Oms906 Lenzumestrocel Aceclofenac JNJ-75276617 CILOSTAZOL More therapies…

    Learn about Your Condition

    Apathy Polyneuropathy Penile cancer Lichenoid keratosis Senile dementia Parkinson's disease Lennox-Gastaut syndrome Intervertebral disc protrusion Brain neoplasm Ebola disease Skin cancer Iron deficiency anaemia Glioma Persistent depressive disorder Giardiasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of cemiplimab with or without chemotherapy for non-small cell lung cancer patients with high PD-L1 levels to reduce rapid disease progression

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cemiplimab
    • Carboplatin
    • Cisplatin
    Italy

  • Study comparing CHF 5993 (beclometasone/formoterol/glycopyrronium) to fluticasone/salmeterol inhalation in adolescents with uncontrolled asthma on medium-dose inhaled therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Salmeterol
    • Fluticasone Propionate
    Germany Italy Spain

  • Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Belgium Denmark France Germany Greece Hungary +4

  • Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Glatiramer Acetate
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST CLDN6 CONJUGATED TO MONOMETHYL AURISTATIN E VIA A CATHEPSIN HYDROLYSABLE DIPEPTIDE VC LINKER
    Austria Belgium Czechia France Germany Ireland +2

  • Study on Relugolix and Radiation Therapy for Patients with Intermediate Risk Prostate Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Relugolix
    Italy

  • Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage I
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Belgium France Germany Hungary Italy The Netherlands +3

  • Study on Prostate Cancer: Comparing Stereotactic Body Radiation Therapy Alone or with Triptorelin and Bicalutamide for Patients with Acinar Cell Prostatic Carcinoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Triptorelin
    • Bicalutamide
    Italy

  • Study on Pembrolizumab as Maintenance Therapy for Patients with Unresectable Stage III Non-Small Cell Lung Cancer After Chemo-Radiotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIA
    • Non-small cell lung cancer stage IIIB
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study on the Effects of Tepotinib and Cetuximab for Patients with Platinum-Resistant Head and Neck Cancer After Immunotherapy Relapse

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Tepotinib
    • Cetuximab
    Italy

  • Study on Alectinib for Patients with ALK+ Stage III Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Alectinib
    Italy
Previous Page
1 … 33 34 35 36 37 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!